Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Global veterinary organizations issue joint statement against antimicrobial resistanceDecember 7, 2018Veterinary organizations in Europe and Canada have issued a joint statement with the American Veterinary Medical Association (AVMA) to ensure oversight of antimicrobial use, mitigation of antimicrobial resistance, and the continuing availability of critical animal and human medications.
